Il-12 expression controlling agent

Details Il-12 expression controlling agent Il-12 expression controlling agent

A - Human Necessities

61

K

A61K 31/728 (2006.01) A61P 3/10 (2006.01) A61P 13/12 (2006.01) A61P 17/00 (2006.01) A61P 17/06 (2006.01) A61P 19/00 (2006.01) A61P 25/00 (2006.01) A61P 27/02 (2006.01) A61P 29/00 (2006.01) A61P 37/04 (2006.01) A61P 37/08 (2006.01) A61P 43/00 (2006.01) C08B 37/08 (2006.01)

Patent

CA 2440744

An object of the present invention is to provide an IL-12 expression controlling agent, an inhibitor of IL-12 expression and an enhancer of IL-12 expression for oral administration, which comprise hyaluronan as an active ingredient. The present invention relates to an interleukin-12 expression controlling agent, which comprises hyaluronan as an active ingredient. Specifically, it is an inhibitor of interleukin-12 expression, which comprises hyaluronan or the pharmaceutically acceptable salt thereof having a weight average molecular weight of from 600,000 to 3,000,000 as an active ingredient, or an enhancer of interleukin-12 expression for oral administration, which comprise hyaluronan or the pharmaceutically acceptable salt thereof having a weight average molecular weight of from 50,000 to 400,000 as an active ingredient.

L'invention concerne des agents de régulation de l'expression d'IL-12, des inhibiteurs d'expression et des agents de potentialisation, destinés à être administrés oralement et contenant de l'acide hyaluronique en tant que principe actif. Elle concerne en particulier des agents de régulation de l'expression de l'interleukine-12 contenant de l'acide hyaluronique en tant que principe actif. Elle concerne plus spécifiquement des agents de régulation de l'expression de l'interleukine-12 contenant de l'acide hyaluronique dont le poids moléculaire moyen en poids est compris entre 600000 et 3000000, ou un sel de cet acide acceptable sur le plan pharmaceutique, en tant que principe actif. Elle concerne enfin des agents de potentialisation de l'expression de l'interleukine-12, à administration orale, contenant de l'acide hyaluronique dont le poids moléculaire moyen en poids est compris entre 50000 et 400000, ou un sel de cet acide acceptable sur le plan pharmaceutique, en tant que principe actif.

Affiliated with

Also associated with

Rating

Il-12 expression controlling agent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Il-12 expression controlling agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Il-12 expression controlling agent will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2078686